Moreover, our results are in agreement with a previous study showing that ADAR1-mediated RNA editing contributes to the prevention of pathogenic immune responses as well as gut inflammation and colitis and inflammatory gastrointestinal problems are sometimes observed in patients with ADAR1 gene mutations (26, 41). The gene discussed is ADAR; the disease is inflammatory response.